70 related articles for article (PubMed ID: 6890331)
1. Pharmacokinetics of liposome encapsulated cisplatin in rats.
Freise J; Mueller WH; Magerstedt P; Schmoll HJ
Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):180-92. PubMed ID: 6890331
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
Kim CK; Han JH
J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
[TBL] [Abstract][Full Text] [Related]
3. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
Allen TM; Everest JM
J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution of iv injection of polyphase liposome-encapsulated cisplatin (KM-1) in rats.
Wang S; Mi JB; Li YZ; Chang WB; Ci YX; Zhao MZ; Zhao YK; Zhu LY; Xu G
Acta Pharmacol Sin; 2003 Jun; 24(6):589-92. PubMed ID: 12791187
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II).
Lautersztain J; Perez-Soler R; Khokhar AR; Newman RA; Lopez-Berestein G
Cancer Chemother Pharmacol; 1986; 18(2):93-7. PubMed ID: 3791565
[TBL] [Abstract][Full Text] [Related]
6. Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).
DeSimone PA; Yancey RS; Coupal JJ; Butts JD; Hoeschel JD
Cancer Treat Rep; 1979 Jun; 63(6):951-60. PubMed ID: 466654
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
Parker RJ; Hartman KD; Sieber SM
Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
[TBL] [Abstract][Full Text] [Related]
8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
9. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
Litterst CL; LeRoy AF; Guarino AM
Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
[TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
Rahman A; Carmichael D; Harris M; Roh JK
Cancer Res; 1986 May; 46(5):2295-9. PubMed ID: 3697976
[TBL] [Abstract][Full Text] [Related]
12. Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats.
Engineer MS; Bodey GP; Newman RA; Ho DH
Drug Metab Dispos; 1987; 15(3):329-34. PubMed ID: 2886307
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids.
Kieler-Ferguson HM; Chan D; Sockolosky J; Finney L; Maxey E; Vogt S; Szoka FC
Eur J Pharm Sci; 2017 May; 103():85-93. PubMed ID: 28263913
[TBL] [Abstract][Full Text] [Related]
14. Changes in pharmacokinetics of cisplatin after hepatic resection in rats.
Hall KS; Lien B; Endresen L; Bergan A; Rugstad HE
Drug Metab Dispos; 1991; 19(4):725-8. PubMed ID: 1680646
[TBL] [Abstract][Full Text] [Related]
15. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
16. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
[TBL] [Abstract][Full Text] [Related]
17. Selective delivery of liposome-associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth.
Yatvin MB; Mühlensiepen H; Porschen W; Weinstein JN; Feinendegen LE
Cancer Res; 1981 May; 41(5):1602-7. PubMed ID: 7194141
[TBL] [Abstract][Full Text] [Related]
18. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
Reed E; Litterst CL; Thill CC; Yuspa SH; Poirier MC
Cancer Res; 1987 Feb; 47(3):718-22. PubMed ID: 3802077
[TBL] [Abstract][Full Text] [Related]
19. Time course of the binding of platinum to subfractions of the kidney cytosol in the cisplatin-treated rat.
Mason R; Hogg S; Edwards IR
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):51-8. PubMed ID: 3715197
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).
Belt RJ; Himmelstein KJ; Patton TF; Bannister SJ; Sternson LA; Repta AJ
Cancer Treat Rep; 1979; 63(9-10):1515-21. PubMed ID: 498151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
